A clinical trial to evaluate the efficacy of wound instillation with ropivacine with fentanyl or dexmedetomidine or morphine for post operative analgesia in patients undergoing mastectomy.
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/11/028900
- Lead Sponsor
- PT BD SHARMA PGIMS ROHTAK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult female patients
Age between 30-70 years
ASA Physical Status Class I & II scheduled for mastectomy with axillary clearance.
Exclusion Criteria
Patients with uncontrolled cardiovascular, pulmonary, hepatic, renal, neurologic, psychiatric diseases or diabetes mellitus; major blood loss during surgery or continued excessive blood collection in to the drains and having allergy to the study drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Pain Score <br/ ><br>2 Duration of analgesia <br/ ><br>3 Need for rescue analgesia <br/ ><br>4 Side effects if anyTimepoint: Intra operative and 24 hour post operative period
- Secondary Outcome Measures
Name Time Method Heart rate Blood pressure Spo2 <br/ ><br>Visual Analogue Score at Rest <br/ ><br>Visual Analogue Score on movementTimepoint: Intra operative and 24 hour post operative period